Drug Type Chemical drugs |
Synonyms Idraparinux, Idraparinux sodium (USAN), 艾卓肝素 + [6] |
Target |
Action inhibitors |
Mechanism factor Xa inhibitors(Factor Xa inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Molecular FormulaC38H64NaO49S7 |
InChIKeyLRWRCXOPMFQZNL-QIEZGXCVSA-N |
CAS Registry149920-56-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D10471 | Idraparinux Sodium | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Venous Thromboembolism | Phase 3 | United States | 01 Nov 2003 | |
Venous Thromboembolism | Phase 3 | Australia | 01 Nov 2003 | |
Venous Thromboembolism | Phase 3 | Austria | 01 Nov 2003 | |
Venous Thromboembolism | Phase 3 | Belgium | 01 Nov 2003 | |
Venous Thromboembolism | Phase 3 | Brazil | 01 Nov 2003 | |
Venous Thromboembolism | Phase 3 | Canada | 01 Nov 2003 | |
Venous Thromboembolism | Phase 3 | Czechia | 01 Nov 2003 | |
Venous Thromboembolism | Phase 3 | Denmark | 01 Nov 2003 | |
Venous Thromboembolism | Phase 3 | Finland | 01 Nov 2003 | |
Venous Thromboembolism | Phase 3 | France | 01 Nov 2003 |
Phase 1 | 757 | lrbcmqawor(jfwfjnobws): ratio estimate = 0.95 (90% CI, 0.87 - 1.04) View more | - | 01 May 2013 | |||
Phase 3 | 4,576 | oefsefezsz(rjvmcdidkz) = jbpxngwcfq exeqhvjxkj (mgjnulxyrn ) View more | Positive | 26 Jan 2008 | |||
vitamin K antagonists | oefsefezsz(rjvmcdidkz) = gclequwitb exeqhvjxkj (mgjnulxyrn ) View more | ||||||
Not Applicable | - | hqhqrldimn(zzpbsofmqk) = zvmvqzwubr yzkfrvvrds (ybvodxebld ) View more | - | 13 Sep 2007 | |||
Standard therapy | hqhqrldimn(zzpbsofmqk) = wzwkszrvey yzkfrvvrds (ybvodxebld ) View more | ||||||
Phase 3 | 1,215 | diwfzxsbmp(lovafggnmq) = vcbktiowox rhknnjbmyl (hkndltfaol ) | - | 13 Sep 2007 |